|
MechanismVMAT2 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date03 Apr 2017 |
100 Clinical Results associated with Actavis Laboratories FL, Inc.
0 Patents (Medical) associated with Actavis Laboratories FL, Inc.
100 Deals associated with Actavis Laboratories FL, Inc.
100 Translational Medicine associated with Actavis Laboratories FL, Inc.